Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FAEYE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,583
Award facts
- Contract value 100% obligated
- $48,582.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $48,582.98 delivery order to Amerisourcebergen Drug Corp on July 23, 2026, for RINVOQ ER 30 MG tablets (30-count unit of use packaging). The ultimate completion date is July 24, 2026.
Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside applied. Amerisourcebergen is a wholly owned subsidiary of Cencora, Inc., and competes without SBA certifications.
Quick answers
Who was awarded contract SPE2DR26FAEYE?
SPE2DR26FAEYE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2026.
How much is contract SPE2DR26FAEYE worth?
The government has obligated $48,583 on SPE2DR26FAEYE.
Is contract SPE2DR26FAEYE an order under another contract?
Yes. SPE2DR26FAEYE is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FAEYE competed?
The extent of competition for SPE2DR26FAEYE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award